| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 03/21/2002 | WO2002023185A2 Devices and methods for direct electronic readout of biomolecular interactions |
| 03/21/2002 | WO2002023156A1 Enhancement of in situ hybridization |
| 03/21/2002 | WO2002022890A2 Compositions, methods and kits for determining the presence of cryptosporidium organisms in a test sample |
| 03/21/2002 | WO2002022889A2 Direct haplotyping using carbon nanotube probes |
| 03/21/2002 | WO2002022888A1 Haplotypes of the scya8 gene |
| 03/21/2002 | WO2002022887A1 Haplotypes of the htr5a gene |
| 03/21/2002 | WO2002022886A2 Expression of genes in diabetes mellitus and insulin resistance |
| 03/21/2002 | WO2002022885A1 Compositions and methods for identifying and targeting stomach and esophageal cancer cells |
| 03/21/2002 | WO2002022884A2 Microarrayed organization of transcription factor target genes |
| 03/21/2002 | WO2002022883A1 Combinatorial fluorescence energy transfer tags and uses thereof |
| 03/21/2002 | WO2002022882A2 Target activated nucleic acid biosensor and methods of using same |
| 03/21/2002 | WO2002022881A1 Endothelin-1 promoter polymorphism |
| 03/21/2002 | WO2002022879A2 Detection of microsatellite instability and its use in diagnosis of tumors |
| 03/21/2002 | WO2002022877A2 Variants of il-1 beta gene and cd46 gene for diagnosing unexplained recurrent pregnancy loss |
| 03/21/2002 | WO2002022876A1 Method of identifying putative antibiotic resistance genes |
| 03/21/2002 | WO2002022875A2 Polymorphisms associated with cardiac arrythmia |
| 03/21/2002 | WO2002022874A2 Oligonucleotides for labeling oligonucleotide probes and proteins |
| 03/21/2002 | WO2002022873A1 Method and kit for determining human geographic or population origin |
| 03/21/2002 | WO2002022872A1 Multiplex pcr method and kit and oligonucleotides for detection and identification of mycobacteria using the multiplex pcr method |
| 03/21/2002 | WO2002022871A2 Polymorphic bone morphogenetic protein 2 |
| 03/21/2002 | WO2002022870A2 Method for the characterization and/or identification of genomes |
| 03/21/2002 | WO2002022869A2 Directed evolution method |
| 03/21/2002 | WO2002022868A2 Method and primers for detecting viral genes |
| 03/21/2002 | WO2002022867A2 Diagnostic and therapeutic use of a phosphoprotein enriched in astrocytes for alzheimer's disease and related neurodegenerative disorders |
| 03/21/2002 | WO2002022866A2 Method and sampling kit for analysing material containing nucleic acid |
| 03/21/2002 | WO2002022865A2 Pcr reaction mixture for fluorescence-based gene analysis and gene mutation analysis |
| 03/21/2002 | WO2002022864A1 The method of detecting mutant dspp gene of hereditary opalescent |
| 03/21/2002 | WO2002022862A2 Methods for identifying modulators of protein interactions |
| 03/21/2002 | WO2002022861A1 Oxygenase enzymes and screening method |
| 03/21/2002 | WO2002022859A2 Assessment of ecosystem health by evaluating multiple biomarkers in a nonhuman organism |
| 03/21/2002 | WO2002022858A1 Id-1 and id-2 genes and products as diagnostic and prognostic markers and therapeutic targets for treatment of breast cancer and other types of carcinoma |
| 03/21/2002 | WO2002022857A2 Methods for the identification of modulators of magnesium chelatase expression or activity in plants |
| 03/21/2002 | WO2002022856A2 Uses of the mammalian ccl18 and related reagents |
| 03/21/2002 | WO2002022855A2 Test-strips with positively charged membranes for tetrazolium based assays |
| 03/21/2002 | WO2002022854A2 Method for the detection and measurement of biomass |
| 03/21/2002 | WO2002022851A2 Novel tumor-associated marker |
| 03/21/2002 | WO2002022850A2 Genome arrays utilizing randomly selected nucleic acid fragments |
| 03/21/2002 | WO2002022836A2 A method for producing plants which are resistant to closteroviruses |
| 03/21/2002 | WO2002022819A2 Calcium binding proteins |
| 03/21/2002 | WO2002022810A2 Combinatorial screening of mixed populations of organisms |
| 03/21/2002 | WO2002022809A2 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST |
| 03/21/2002 | WO2002022806A2 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses tehreof |
| 03/21/2002 | WO2002022805A2 Modulation of il-2- and il-15-mediated t cell responses |
| 03/21/2002 | WO2002022795A2 Isolated human kinase proteins, nucleic acid molecules and uses thereof |
| 03/21/2002 | WO2002022794A2 ENDOTHELIN CONVERTING ENZYMES AND THE AMYLOID βPEPTIDE |
| 03/21/2002 | WO2002022786A1 Method and cell composition for screening compounds for anti-inflammatory activity |
| 03/21/2002 | WO2002022785A1 Improvements in or relating to selective agents for biological cultures |
| 03/21/2002 | WO2002022783A2 Liver gene expression associated with the inhibition of hbv replication or transcription |
| 03/21/2002 | WO2002022781A2 Non-nucleoside reverse transcriptase inhibitor as antiretroviral therapy |
| 03/21/2002 | WO2002022778A2 Ab initio physics-based gene identification method |
| 03/21/2002 | WO2002022685A2 Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom |
| 03/21/2002 | WO2002022684A2 Transporters and ion channels |
| 03/21/2002 | WO2002022682A1 Interferon-alpha induced gene |
| 03/21/2002 | WO2002022681A2 Neuronally expressed protein and use thereof |
| 03/21/2002 | WO2002022678A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/21/2002 | WO2002022664A2 Antigenic proteins of shrimp white spot syndrome virus and uses thereof |
| 03/21/2002 | WO2002022661A2 NOVEL PDEs AND USES THEREOF |
| 03/21/2002 | WO2002022652A2 Haplotypes of the slc18a2 gene |
| 03/21/2002 | WO2002022651A2 Haplotypes of the ccr8 gene |
| 03/21/2002 | WO2002022650A2 Haplotypes of the per1 gene |
| 03/21/2002 | WO2002022649A2 Screening methods to identify g-proteins and other compounds which modulate phosphodiesterase (pde) activity |
| 03/21/2002 | WO2002022648A2 Compositions and methods for inducing specific cytolytic t cell responses |
| 03/21/2002 | WO2002022644A1 Haplotypes of the gpr7 gene |
| 03/21/2002 | WO2002022643A1 Haplotypes of the chrng gene |
| 03/21/2002 | WO2002022638A1 22 human secreted proteins |
| 03/21/2002 | WO2002022631A2 Regulation of human pyroglutamyl peptidase-like enzyme |
| 03/21/2002 | WO2002022161A2 The diagnosis, prevention, and/or treatment of atherosclerosis and underlying and/or related diseases |
| 03/21/2002 | WO2002022160A2 The diagnosis, prevention, amelioration and/or treatment of disturbed immune function induced by disturbed lipid metabolism |
| 03/21/2002 | WO2002022138A1 Antibacterial agents and methods of identification |
| 03/21/2002 | WO2002022078A2 Enzyme method for detecting sphingosine-1-phosphate (s1p) |
| 03/21/2002 | WO2002022076A2 Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids |
| 03/21/2002 | WO2002021996A2 Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators |
| 03/21/2002 | WO2002000927A8 Diagnosis of diseases associated with development by means of assessing their methylation status |
| 03/21/2002 | WO2001096867A3 Method for identifying insulin mimics or antagonists |
| 03/21/2002 | WO2001096388A8 Compositions and methods for the therapy and diagnosis of colon cancer |
| 03/21/2002 | WO2001087039A3 Treatment of neoplasia / transformation using pituitary tumor transforming gene 2 |
| 03/21/2002 | WO2001085979A3 Stabilized composition |
| 03/21/2002 | WO2001085742A3 Haplotypes of the npy1r gene |
| 03/21/2002 | WO2001084145A3 Device for monitoring analytes at sub-micromolar concentrations |
| 03/21/2002 | WO2001079974A3 Haplotypes of the f9 gene |
| 03/21/2002 | WO2001079523A3 Method and system for microorganism identification by mass spectrometry-based proteome database searching |
| 03/21/2002 | WO2001079237A3 Haplotypes of the galr1 gene |
| 03/21/2002 | WO2001079231A3 Haplotypes of the npr1 gene |
| 03/21/2002 | WO2001079230A3 Haplotypes of the ugt1a1 gene |
| 03/21/2002 | WO2001079223A3 Haplotypes of the akr1b1 gene |
| 03/21/2002 | WO2001079217A3 Haplotypes of the scya3 gene |
| 03/21/2002 | WO2001077376A8 Diagnosis of diseases associated with metastasis |
| 03/21/2002 | WO2001077164A8 Diagnosis of diseases associated with apoptosis by means of assessing the methylation status of genes associated with apoptosis |
| 03/21/2002 | WO2001077131A3 Haplotypes of the bglap gene |
| 03/21/2002 | WO2001077130A3 Haplotypes of the apoa2 gene |
| 03/21/2002 | WO2001077129A3 Haplotypes of the apoc1 gene |
| 03/21/2002 | WO2001075065A3 Haplotypes of the gp1ba gene |
| 03/21/2002 | WO2001074902A3 Adenine binding g protein coupled receptors |
| 03/21/2002 | WO2001073124A3 Rapid response glucose sensor |
| 03/21/2002 | WO2001072841A3 Isolated human g-protein coupled receptors that are members of the aminergic subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 03/21/2002 | WO2001072840A3 Isolated human g-protein coupled receptors of the mas proto-oncogene subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 03/21/2002 | WO2001068818A3 Hcv ns2/3 fragments and uses thereof |
| 03/21/2002 | WO2001068664A3 Mass labels |
| 03/21/2002 | WO2001064840A8 Novel bone marrow nucleic acids and polypeptides |
| 03/21/2002 | WO2001062905A3 Integrin antagonists |